TrialBritish journal of clinical pharmacology2021

Endothelial-protective effects of a G-protein-biased sphingosine-1 phosphate receptor-1 agonist, SAR247799, in type-2 diabetes rats and a randomized placebo-controlled patient trial.

Luc Bergougnan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.